D-0831-2020 Class II Terminated
FDA drug recall D-0831-2020 was initiated by Teva Pharmaceuticals USA on January 27, 2020 and is designated Class II. Reason for recall: GMP Deviations: Product bottle may be absent of desiccant. The recall status is terminated (terminated December 10, 2020). Affected quantity: 69,012 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- February 12, 2020
- Initiation Date
- January 27, 2020
- Termination Date
- December 10, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 69,012 bottles
Product Description
Desmopressin Acetate Tablets, 0.2 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2465-01
Reason for Recall
GMP Deviations: Product bottle may be absent of desiccant.
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: 1269726M, exp. date 01/2020; 1283269M, 1283270M, exp. date 03/2020; 1292992M,1292993A, exp. date 04/2020